Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68071-5167

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-5167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5167 4)

The packaging label for Ondansetron 8 mg orally disintegrating tablets (ODT) by NuCare Pharmaceuticals, Inc. It displays the NDC 68071-5167 and includes dosage, manufacturer details (Aurobindo Pharma Limited, Hyderabad, India), packaging instructions, and warnings. The label notes phenylketonurics information and storage temperature instructions.*

FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical structure of Ondansetron, showing its molecular framework with nitrogen-containing rings, a ketone group, and methyl substituents as part of the active ingredient's molecular formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.